Indian biotech firm Panacea Biotec Ltd said on Wednesday it would
partner with U.S.-based Refana Inc to make a potential vaccine for
COVID-19.
The collaboration aims to make more than 500 million doses of the
vaccine candidate, with over 40 million doses expected to be available
early next year, Panacea said in a statement to stock exchanges.
https://www.reuters.com/article/us-health-coronavirus-india-vaccine/indian-firm-panacea-says-aiming-to-make-covid-19-vaccine-idUSKBN23H0LL
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.